Source comparison
TB-500 for Women Over 40: Dosage and Protocol Comparison
Acute Injury Recovery 4–5mg Twice weekly 4–6 weeks Accelerate healing of specific soft tissue injury (tendon, ligament, muscle strain) Highest-dose protocol; appropriate for localized tissue damage with clear onset. Taper to maintenance after inflammation reso
This comparison does not assign a generated winner or score.
- Acute Injury Recovery
- 4–5mg
- Twice weekly
- 4–6 weeks
- Accelerate healing of specific soft tissue injury (tendon, ligament, muscle strain)
- Highest-dose protocol; appropriate for localized tissue damage with clear onset. Taper to maintenance after inflammation resolves.
- Chronic Inflammation Management
- 2–3mg
- 8–12 weeks
- Reduce systemic inflammatory markers; support joint health in multiple sites
- Lower dose sustained over longer period allows cumulative repair without overstimulating immune response. Best for diffuse joint pain.
- Longevity and Tissue Maintenance
- 1–2mg
- Once weekly
- Ongoing (12+ weeks)
- Maintain baseline thymosin beta-4 levels; prevent age-related repair decline
- Maintenance dosing after initial recovery phase. Not curative. Maintains cellular repair capacity at physiologically younger levels.
- Post-Surgical Tissue Repair
- 3–4mg
- Three times weekly
- 3–4 weeks post-op
- Support wound closure; reduce scar tissue formation; accelerate return to activity
- Short, intense protocol immediately following surgical intervention. Coordinate timing with prescribing physician.
- Dosing variables matter significantly. Subcutaneous injection is standard. Intramuscular administration shows no absorption advantage and increases injection site soreness. Reconstitution requires bacteriostatic water (not sterile water) to maintain peptide stability across multiple draws; once mixed, TB-500 remains stable for 28 days when refrigerated at 2–8°C. Lyophilized (freeze-dried) powder stored at −20°C maintains potency for 24+ months, but any temperature excursion above 8°C after reconstitution causes irreversible protein denaturation.
- The biggest preparation error: injecting air into the vial while drawing solution. Positive pressure inside the vial forces peptide solution back through the needle during withdrawal, contaminating subsequent draws and reducing effective dose. Always equalize pressure by drawing an equivalent volume of air before injecting bacteriostatic water, then allow the powder to dissolve passively without shaking (which denatures protein structure).